Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Social Psychiatry and Psychiatric Epidemiology
Published in: Social Psychiatry and Psychiatric Epidemiology 1/2013

01-01-2013 | Original Paper

Prevalence and treatment of 12-month DSM-IV disorders in the Northern Ireland study of health and stress

Authors: Brendan Bunting, Samuel Murphy, Siobhan O’Neill, Finola Ferry

Published in: Social Psychiatry and Psychiatric Epidemiology | Issue 1/2013

Login to get access

Abstract

Purpose

Prior to the current Northern Ireland Study of Health and Stress there have been no epidemiological studies which estimate the prevalence and treatment of mental health disorders across Northern Ireland based on validated diagnostic criteria. This paper provides the first nationally representative estimates of 12-month DSM-IV anxiety, mood, impulse-control and substance disorders. Severity, demographic correlates, treatment and treatment adequacy of 12-month disorders are also examined.

Methods

Data were derived from a nationally representative face-to-face household survey of 4,340 participants (2,441 females and 1,899 males) aged 18 years and older living in Northern Ireland using the World Health Organization Composite International Diagnostic Interview. Analyses were implemented using the SUDAAN software system.

Results

12-month prevalence estimates were anxiety 14.6 %; mood 9.6 %; impulse control 3.4 %; substance 3.5 %; any disorder 23.1 %. Of the 12-month cases, 28.8 % were classified as serious; 33.4 % as moderate; and 37.8 % as mild. Females were more likely to have anxiety and mood disorders (p < 0.05) while males were more likely to have impulse-control and substance disorders. Just 40 % of individuals with any 12-month DSM-IV disorder received treatment in the previous 12 months. 78.6 % of those with a mental disorder who sought treatment received minimally adequate treatment.

Conclusions

12-month DSM-IV disorders are highly prevalent in Northern Ireland. A large proportion of those with mental health problems did not seek treatment. Further research is required to investigate the reasons behind low levels of treatment contact.
Literature
1.
Ferry F, Bolton D, Bunting B, Devine B, McCann S, Murphy S (2008) Trauma, health and conflict in Northern Ireland. A study of the epidemiology of trauma related disorders and qualitative investigation of the impact of trauma on the individual. Northern Ireland Centre for Trauma and Transformation and University of Ulster Psychology Research Institute, Londonderry
2.
Muldoon O, Schmid K, Downes C, Kremer J, Trew K (2003) The legacy of the troubles: experience of the troubles, mental health and social attitudes. Queen’s University, Belfast
3.
Fay MT, Morrissey M, Smyth M, Wong T (1999) The cost of the troubles study: report on the Northern Ireland survey. The experience and impact of the troubles. INCORE, Derry/Londonderry
4.
O’Reilly D, Stevenson M (2003) Mental health in Northern Ireland: have the “troubles” made it worse? J Epidemiol Commun Health 57:488–492CrossRef
5.
6.
7.
World Health Organisation (1992) The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. WHO, Geneva
8.
McConnell P, Bebbington P, McClelland R, Gillespie K, Houghton S (2002) Prevalence of psychiatric disorder and the need for psychiatric care in Northern Ireland: population study in the district of Derry. Br J Psychiatry 181:214–219PubMedCrossRef
9.
10.
11.
Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC (2005) Twelve-month use of mental health services in the United States; results from the national comorbidity survey replication. Arch Gen Psychiatry 62:629–640PubMedCrossRef
12.
Wang PS, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Borges G, Bruffaerts R et al (2008) Delay and failure in treatment seeking after first onset of mental disorders in the world mental health survey initiative. In: Kessler RC, Üstün TB (eds) The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders. Cambridge University Press, New York, pp 522–533
13.
American Psychiatry Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC
14.
Kessler RC, Üstün TB (2008) The world health organization composite international diagnostic interview. In: Kessler RC, Üstün TB (eds) The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders. Cambridge University Press, New York, pp 58–90
15.
Sheehan DV, Harnett-Sheehan K, Raj BA (1996) The measurement of disability. Int Clin Psychopharmacol 11:89–95PubMedCrossRef
16.
American Psychiatric Association (2002) Practice guideline for treatment of patients with bipolar disorder, 2nd edn. American Psychiatric Association Press, Washington, DC
17.
Katon WJ, Roy-Byrne P, Russo J, Cowley D (2002) Cost-effectiveness and cost offset of a collaborative care intervention for primary care patients with panic disorder. Arch Gen Psychiatry 59:1098–1104PubMedCrossRef
18.
Wells KB, Sherbourne C, Schoenbaum M, Duan N, Meredith L, Unutzer J et al (2000) Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. JAMA 283:212–220PubMedCrossRef
19.
American Psychiatric Association (1998) Practice guideline for treatment of patients with panic disorder. American Psychiatric Association Press, Washington, DC
20.
National Committee for Quality Assurance (1997) Narrative: what’s in it and why it matters. National Committee for Quality Assurance, Washington, DC
21.
Katon W, Von Korff M, Lin E, Walker E, Simon GE, Bush T et al (1995) Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA 273:1026–1031PubMedCrossRef
22.
Wolter KM (1985) Introduction to variance estimation. Springer, New York
23.
SUDAAN (2002) Version 8.01. Research Triangle Institute, Research Triangle Park, NC
24.
Hosmer DW, Lemeshow S (eds) (1989) Applied logistic regression. Wiley, New York
25.
Gunn J, Maden A, Swinton M (1991) Treatment needs of prisoners with psychiatric disorders. BMJ 303:338–341PubMedCrossRef
26.
Lamb HR, Weinberger LE (1998) Persons with severe mental illness in jails and prisons: a review. Psychiatr Serv 49(4):483–492PubMed
27.
Brown MN, Lapane KL, Luisi AF (2002) The management of depression in older nursing home residents. J Am Geriatr Soc 50:69–76PubMedCrossRef
28.
Kessler RC, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Borges G, Bromet EJ et al (2008) Prevalence of mental disorders in the world mental health survey initiative. In: Kessler RC, Üstün TB (eds) The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders. Cambridge University Press, New York, pp 534–540
29.
Kessler RC, Berglund PA, Chiu WT, Demlar O, Glantz M, Lane MC et al (2008) The national comorbidity survey replication (NCS-R): the cornerstone in improving mental health and mental health care in the United States. In: Kessler RC, Üstün TB (eds) The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders. Cambridge University Press, New York, pp 165–210
30.
National Collaborating Centre for Mental Health (2009) Depression in adults. Depression: the treatment and management of depression in adults. The British Psychological Society and Gaskell, Leister
31.
Herman AA, Williams D, Stein DJ, Seedat S, Heeringa SG, Moomal H (2008) The South African health and stress study (SASH): a foundation for improving mental health care in South Africa. In: Kessler RC, Üstün TB (eds) The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders. Cambridge University Press, New York, pp 238–264
32.
Alonso J, Kessler RC (2008) Prevalence and treatment of mental disorders in Germany: results from the European study of epidemiology of mental disorders (ESEMeD) survey. In: Kessler RC, Üstün TB (eds) The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders. Cambridge University Press, New York, pp 331–345
33.
Arababzadeh-Bouchez S, Gasquet I, Kovess-Masfety V, Negres-Pages L, Lépine J-P (2008) The prevalence of mental disorders and service use in France: results from a national survey 2001–2002. In: Kessler RC, Üstün TB (eds) The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders. Cambridge University Press, New York, pp 305–330
34.
Singleton N, Bumpstead R, O’Brien M, Lee A, Meltzer H (2000) Psychiatric morbidity among adults living in private households. TSO, London
35.
Wang PS, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Borges G, Bromet EJ et al (2008) Recent treatment of mental health disorders in the world mental health survey initiative. In: Kessler RC, Üstün TB (eds) The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders. Cambridge University Press, New York, pp 511–521
36.
Seedat S, Stein DJ, Herman A, Kessler R, Sonnega J, Heeringa S et al (2008) Twelve-month treatment of psychiatric disorders in the South African stress and health survey (world mental health survey initiative). Soc Psychiatry Psychiatr Epidemiol 43(11):889–897PubMedCrossRef
37.
Shen YC, Zhang M-Y, Huang Y-Q, He Y-L, Liu Z-R, Cheng H et al (2006) Twelve month prevalence, severity, and unmet need for treatment of mental disorders in metropolitan China. Psychol Med 36(2):257–267PubMedCrossRef
38.
Alonso J, Angermeyer M, Bernert S, Bruffaerts R, Brugha TS, Bryson H et al (2004) Use of mental health services in Europe: results from the European study on epidemiology of mental disorders (ESEMeD) Project. Acta Psychiatr Scand 109(Suppl 420):47–54
39.
40.
Meltzer H, Bebbington P, Brugha T, Farrell M, Jenkins R, Lewis G (2003) The reluctance to seek treatment for neurotic disorders. Int Rev Psychiatry 15(1–2):123–128PubMedCrossRef
41.
Mojtabai R (2010) Mental illness stigma and willingness to seek mental health care in the European Union. Soc Psychiatry Psychiatr Epidemiol 45(7):705–712PubMedCrossRef
42.
Ten Have M, de Graaf R, Ormel J, Vialgut G, Kovess V, Alonso J (2010) Are attitudes towards mental health help-seeking associated with service use? Results from the European Study of Epidemiology of Mental Disorders. Soc Psychiatry Psychiatr Epidemiol 45(2):153–163PubMedCrossRef
43.
Naganuma Y, Tachimori H, Kawakami N, Takeshima T, Ono Y, Uda H et al (2006) Twelve-month use of mental health services in four areas in Japan: findings from the world mental health Japan survey. Psychiatry Clin Neurosci 60(2):240–248PubMedCrossRef
44.
Levinson D, Lerner Y, Zilber N, Grinshpoon A, Levav I (2007) Twelve-month service utilization rates for mental health reasons: data from the Israel national health survey. Isr J Psychiatry Relat Sci 44(2):114–125PubMed
45.
Wang PS, Aguilar-Gaxiola S, Alonso J, Bromet EJ, Angermeyer MC, Borges G et al (2008) Recent treatment of mental disorders in the world mental health survey initiative. In: Kessler RC, Üstün TB (eds) The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders. Cambridge University Press, New York, pp 541–554
46.
Cunningham JA, Sobell LC, Sobell MB, Agrawal S, Toneatto T (1993) Barriers to treatment: why alcohol and drug abusers delay or never seek treatment. Addict Behav 18(3):347–353PubMedCrossRef
47.
Saunders S, Zygowicz K, D’Angelo B (2006) Person-related and treatment-related barriers to alcohol treatment. J Subst Abuse Treat 30(3):261–270PubMedCrossRef
48.
Oakley-Browne MA, Wells JE, Scott KM (2008) Te Rau Hinengaro: the New Zealand mental health survey. In: Kessler RC, Üstün TB (eds) The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders. Cambridge University Press, New York, pp 486–510
49.
Medina-Mora ME, Borges G, Lara C, Benjet C, Blanco J, Fleiz C et al (2005) Prevalence, service use, and demographic correlates of 12-month DSM-IV psychiatric disorders in Mexico: results from the Mexican national comorbidity survey. Psychol Med 35(12):1773–1783PubMedCrossRef
50.
Metadata
Title
Prevalence and treatment of 12-month DSM-IV disorders in the Northern Ireland study of health and stress
Authors
Brendan Bunting
Samuel Murphy
Siobhan O’Neill
Finola Ferry
Publication date
01-01-2013
Publisher
Springer-Verlag
Published in
Social Psychiatry and Psychiatric Epidemiology / Issue 1/2013
Print ISSN: 0933-7954
Electronic ISSN: 1433-9285
DOI
https://doi.org/10.1007/s00127-012-0518-5

Other articles of this Issue 1/2013

Social Psychiatry and Psychiatric Epidemiology 1/2013 Go to the issue

Original Paper

Social inequalities in depression and suicidal ideation among older primary care patients

Original Paper

Cognitive deficits and ethnicity: a cohort study of early psychosis patients in The Netherlands

Original Paper

Experiences with treating immigrants: a qualitative study in mental health services across 16 European countries

Original Paper

Modeling the geographic distribution of serious mental illness in New Zealand

Original Paper

Combined influence of serious mental illness and criminal offending on suicide risk in younger adults

Original Paper

Determinants of negative pathways to care and their impact on service disengagement in first-episode psychosis